Home › [Newsmaker] Samsung's first biosimilar drug gains domestic approval
 

Keywords :   


[Newsmaker] Samsung's first biosimilar drug gains domestic approval

2015-09-08 11:51:41| Biotech - Topix.net

Samsung Group, South Korea's leading conglomerate, has taken a significant step toward driving forward its newly-established biopharmaceuticals business, an emerging sector expected to become one of the company's future growth engines. Samsung Bioepis, the conglomerate's biotechnology research and development unit, said Monday that it had gained approval from the Ministry of Food and Drug Safety to begin selling Brenzys, its biosimilar copy of Pfizer's rheumatoid arthritis treatment Enbrel, in South Korea.

Tags: drug approval domestic gains

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Forecast Discussion Number 27
05.07Hurricane Beryl Public Advisory Number 27
05.07Hurricane Beryl Wind Speed Probabilities Number 27
05.07Hurricane Beryl Forecast Advisory Number 27
05.07Tropical Depression Aletta Graphics
05.07Tropical Depression Aletta Forecast Discussion Number 4
05.07Tropical Depression Aletta Wind Speed Probabilities Number 4
More »